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Abstract The activities of the sialyltransferase enzymes and the 
resulting expression of sialoglycoproteins were examined in 
tumor cells derived from different tissues in order to gain a 
greater understanding of the factors controlling the cell glycosyl- 
ation state. Cell-cell contact, which is dependent on cell conflu- 
ency state, was shown to influence glycosylation in the neurally- 
derived mouse neuro-2A neuroblastoma nd the C6 glioma cell 
lines. Both showed a relatively high level of cell sialyltransferase 
activity under sub-confluent conditions with activity decreasing 
upon the formation of cell-cell contacts associated with conflu- 
ency. A parallel decrease in the expression of sialoglycoproteins, 
as determined by lectin blot analysis, was also observed under 
these conditions. In contrast, the H411e hepatoma cell line 
showed an increase in enzyme activity with confluency with the 
susceptibility of the enzyme in this cell line to glucocorticoid 
induction only being detected in sub-confluent cell cultures. The 
number of trypsinisation cycles of the cells was also shown to 
affect the enzyme activity of the neuro-2A and C6 cells with an 
increase in enzyme activity coincident with passage number being 
observed in the neuro-2A cells, and a decrease in the C6 glioma 
cell line. Trypsinisation had no effect on enzyme activity in the 
H411e cells. These results demonstrate that the control of sia- 
lyitransferase activity in tumor cells is multifactorial with the 
tissue of origin playing a key role. 
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each transfer being catalysed by an individual sialyl-T isozyme 
[4]. Sialic acid can in addition be transferred to sialic acid 
residues in c~2,8 linkages to form polysialic acid chains (PSA) 
of up to 50 residues in length, which are expressed in a develop- 
mentally regulated manner on the neural cell adhesion mole- 
cule, NCAM [5]. The expression of protein-bound sialic acid 
is altered in certain tumor cell lines where it acts to influence 
cell adhesivity and consequently the invasive or metastatic po- 
tential of the cell [6]. Tumor cells with significant metastatic 
potential tend to have a high sialyl-T activity [7], and treatment 
of adenocarcinoma cells with an enzyme inhibitor was demon- 
strated to decrease metastasis [8]. 
While the role of cellular transcription factors and oncogenes 
[9], and also external agents uch as glucocorticoids and cytok- 
ines [10-12] in the control of sialyl-T activity have been well 
characterised, the role of cell-cell interaction i  this process has 
not been addressed. As cell adhesion molecule (CAM) medi- 
ated cell-cell contact can activate a cellular signalling mecha- 
nism [13] and has previously been demonstrated to influence the 
expression of cell surface adhesion ligands [14], it was of interest 
to examine the effect of cell-cell contact on both basal sialyl-T 
expression in cell lines derived from different issues and also 
to observe the enzyme susceptibility to regulation by external 
factors such as corticosteroids under various states of cell con- 
fluency. 
2. Materials and methods 
1. Introduction 
Tumor cells express altered glycosylation characteristics with 
an over-expression f the negatively charged sialic acid sugar 
in particular being associated with an increase in tumor metas- 
tatic potential [1]. The final stage in the biosynthetic pathway 
of sialoglycoconjugates is partly controlled by the sialyltrans- 
ferase (sialyl-T) enzymes, which belong to the glycosyltrans- 
ferase enzyme family, and which catalyse the transfer of acti- 
vated sialic acid (CMP-Neu5Ac) to terminal positions on the 
oligosaccharide chains of glycoproteins and glycolipids at the 
level of the Golgi. Removal of sialic acid from the glycoconju- 
gate can subsequently be effected by the action of the neuram- 
inidase enzyme which is located primarily in the lysosome [2] 
but which has also been demonstrated at the level of the plasma 
membrane [3]. Sialic acid can be joined onto a number of 
acceptor sugars including galactose, N-acetyl galactosamine 
and N-acetyl glucosamine in both ~2,3 and ~2,6 linkages, with 
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2.1. Cell culture 
N euro-2A mouse neuroblastoma cells, C6 rat glioma cells and H41 l e 
rat hepatoma cells were cultured, as previously described, in Dulbecco's 
modified Eagle's medium containing 10% fetal calf serum (FCS), 1% 
(v/v) penicillin and 1% (v/v) streptomycin [14]. Cells were split (pas- 
saged) by trypsinisation and reseeded at a density of 5 x 105 cells 
(neuro-2A and C6) or 7.5 x 105 cells (H41 le) per 75 cm 2 flask and the 
cell confluency status monitored by nuclear counting using the crystal 
violet stain [15]. At specific stages, the cells were harvested by scraping 
and resuspended bysonication i  water containing protease inhibitors. 
The protein content of the samples was determined by the method of 
Lowry et al. [16]. 
2.2. Sialyhran6ferase ssay 
Total sialyltransferase activity was determined as previously de- 
scribed [3] using cytidine-5-monophosphate-4,5,6,7,8,9-~4C-N-ace- 
tylneuraminic a id (CMpjac-Neu5Ac, Radiochemical Centre, Amer- 
sham; specific activity 293 mCi/mmol) as the sialic acid donor asialofe- 
tuin as an exogenous acceptor. 
2.3. Glycoprotein a alysis 
Glycoconjugate expression was determined by lectin blot analysis as 
previously described [17]. Briefly, 50 #g protein samples were separated 
by discontinuous SDS polyacrylamide g l electrophoresis and trans- 
ferred to PVDF membranes (Millipore) by electroblotting. Glycopro- 
teins containing sialic acid attached to Gal residues in c~2,3-1inkages and 
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sialic acid attached to Gal/GalNAc residues in ~z2,6-1inkages were de- 
tected using the Maackia amurensis and Sambucus nigra lectins respec- 
tively and visualised using the DIG Glycan Differentiation Kit 
(Boehringer Mannheim). 
3. Results and discussion 
Sialoglycoproteins play different roles in particular tissues 
within the body. In the nervous ystem, for example, the major- 
ity of sialoglycoproteins are membrane-bound and play a key 
role in the mediation of cell-cell interactions [18]. In the liver, 
the majority of sialoglycoproteins are soluble proteins which 
are released upon stimulation, for example, as part of the acute- 
phase immune response [19]. 
In this study, we have examined the activity of the sialyl-T 
enzyme, as well as the expression of sialoglycoproteins, in a 
number of tumor cell lines derived from different issues with 
a particular interest in the role of cell contact on these parame- 
ters. In the embryonic nervous ystem in vivo, there is a devel- 
opmentally-regulated d crease in sialyl-T activity which corre- 
sponds well with the onset of cell--cell adhesion and synapto- 
genesis [3,20,2 I] with subsequent alterations in the developmen- 
tal expression of sialoglycoproteins causing an upset in neu- 
ronal patterning with consequent mental deficits [22,23]. Sialyl- 
T activity decreased significantly in parallel with the attainment 
of confluency in both the neuro-2A neuroblastma and C6 gti- 
oma cell lines (Fig. 1 ). This parallels the time course previously 
observed in viw) [24] and was accompanied in the neuro-2A 
cells by a general decrease in the expression of both c~2,3- and 
cz2,6-1inked sialoglycoproteins (Fig. 2). Interestingly, although 
the enzyme activity is highest on day 1 after seeding, the expres- 
sion of sialoglycoproteins is low and does not reach a maximum 
until day 2. This is probably due to the cleavage of cell surface 
glycoproteins during the trypsinisation procedure, which is fol- 
lowed by a delay in the re-expression of these proteins. Altered 
neuraminidase activity may also be responsible for this anom- 
aly. 
In contrast o the neuronal cell lines, sialyl-T activities in the 
H41 le hepatoma cell line increased in parallel with cell conflu- 
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Fig. 1. The effect of increasing cell confluency state on total cellular 
sialyltransferase activity. Activities are expressed as a percentage ofthe 
activity per mg protein on day 1 post-plating and represent 
mean + S.E.M. (n = 3). 
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Fig. 2. The effect of cell confluency state on the expression of lA) c~2,3- 
and (B) :z2,6-1inked sialoglycoproteins in Neuro-2A cells. The migra- 
tion of molecular weight standards i indicated. 
ency state (Fig. 1). This may reflect the differing role of the 
enzyme and the sialoglycoprotein substrates in the two cell lines 
derived from distinct issues. Sialoglycoproteins play a pivotal 
role in cell--cell interaction in the neural cell lines, with the cells 
in a deadhesive state expressing relatively high levels of sialic 
acid in the early developmental stage. In the hepatoma cells, 
however, sialoglycoproteins are mainly secreted by the cell in 
response to certain stimuli, such as inflammation and it is likely, 
therefore, that the cells will be required to maintain a significant 
enzyme activity in the mature confluent state. 
Although previous tudies have demonstrated sialyl-T activ- 
ity to be inducible by the synthetic glucocorticoid exam- 
ethasone in hepatoma cells [l 1,25], enzyme induction in the 
H41 le cells was shown to be influenced by the confluency state 
of the cells, with significant induction only being observed in 
non-confluent cell cultures (Fig. 3). As an increase in the release 
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Fig. 3. The effect of cell confluency on dexamethasonc i duction of 
sialyl-T activity in H41 le cells. The cells were plated at day 0 and were 
treated with dexamethasone (10 ~ M) for 18 h prior to harvesting on 
days 1, 2, 3 and 4 post-plating. Results are expressed as mean _+ S.E.M. 
(n = 3). *indicates P < 0.05 vs. control (Students t-test). 
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Fig. 4. The effect of increasing passage number on the sialyl-T activities 
in Neuro-2A and C6 cells (n = 1). 
of acute-phase glycoproteins from the liver in response to 
agents uch as corticosteroids have been characterised in vivo, 
this loss of dexamethasone-stimulated enzyme induction in 
confluent hepatoma cell cultures may reflect the tumorogenic 
nature of the cells with cell-contact inhibition altering the re- 
sponsiveness of the cells to external stimuli. 
These results support previous studies which have demon- 
strated that tumor cell lines may display modified characteris- 
tics in culture which include alterations in the cell surface glyco- 
sylation state [7], sialic acid being particularly identified as a 
sugar residue whose expression is upset in tumor cells subse- 
quent o alterations in sialyl-T activity [26,27]. Therefore, while 
tumor cells may retain certain characteristics of the parent 
tissue in vitro, others may be lost with these changes being 
particularly exacerbated by factors such as increasing durations 
of time in culture. In order to examine this, we investigated the 
effect of increasing passage number on cellular sialyl-T activity. 
Again, there was a particular variability between the three cell 
lines examined. An increase in sialyl-T activity was observed in 
the neuro-2A cells with the C6 cells showing a decrease in 
enzyme activity with increasing time in culture (Fig. 4). No 
effect of culture duration was observed on the sialyl-T activity 
of the H41 le cell line (data not shown). Therefore, these varia- 
tions may reflect the different phenotypes of the cells or may 
also be explained by their metastatic states. However, the re- 
sults do suggest hat cells in culture over extended periods of 
time may display significantly altered glycosylation characteris- 
tics and this factor should be considered when studies on pro- 
tein glycosylation are being carried out. 
While this study has demonstrated that tumor cell lines re- 
flect certain characteristics of the parent tissue such as cell- 
contact inhibition of neural cell glycosylation, care should be 
taken before directly extrapolating the results to the in vivo 
situation. 
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